| 000 | 01753 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513050402.0 | ||
| 264 | 0 | _c19950331 | |
| 008 | 199503s 0 0 eng d | ||
| 022 | _a0041-1132 | ||
| 024 | 7 |
_a10.1046/j.1537-2995.1995.35395184275.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShapiro, A | |
| 245 | 0 | 0 |
_aLow risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components. International Factor Safety Study Group. _h[electronic resource] |
| 260 |
_bTransfusion _cMar 1995 |
||
| 300 |
_a204-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aFactor IX _xtherapeutic use |
| 650 | 0 | 4 |
_aFactor VII _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xprevention & control |
| 650 | 0 | 4 |
_aHemophilia B _xdrug therapy |
| 650 | 0 | 4 |
_aHepatitis B _xprevention & control |
| 650 | 0 | 4 |
_aHepatitis C _xprevention & control |
| 650 | 0 | 4 | _aHot Temperature |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPlasma _xvirology |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aVirus Diseases _xprevention & control |
| 650 | 0 | 4 | _aVolatilization |
| 700 | 1 | _aAbe, T | |
| 700 | 1 | _aAledort, L M | |
| 700 | 1 | _aAnderle, K | |
| 700 | 1 | _aHilgartner, M W | |
| 700 | 1 | _aKunschak, M | |
| 700 | 1 | _aPreston, F E | |
| 700 | 1 | _aRivard, G E | |
| 700 | 1 | _aSchimpf, K | |
| 773 | 0 |
_tTransfusion _gvol. 35 _gno. 3 _gp. 204-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1537-2995.1995.35395184275.x _zAvailable from publisher's website |
| 999 |
_c7878046 _d7878046 |
||